Prioritising action on diabetes during COVID-19
S Afr Med J
.
2020 Jun 25;110(8):719-720.
Authors
A Erzse
1
,
H Fraser
,
N Levitt
,
K Hofman
Affiliation
1
SAMRC/Wits Centre for Health Economics and Decision Science, PRICELESS, University of the Witwatersrand School of Public Health, Faculty of Health Sciences, Johannesburg, South Africa. agnes.erzse@wits.ac.za.
PMID:
32880294
No abstract available
Publication types
Editorial
Comment
MeSH terms
Betacoronavirus
COVID-19
Centers for Disease Control and Prevention, U.S.
China
Coronavirus Infections*
Coronavirus*
Diabetes Mellitus / epidemiology*
Humans
Pandemics*
Pneumonia, Viral*
SARS-CoV-2
United States